As reported in a study conducted in 23 nations, including over 60% of the world’s population, acceptance of COVID-19 vaccines rose from 75.2% in 2021 to 79.1% in 2022. Nonetheless, vaccination rates dropped in eight nations, and several vaccinated respondents, especially those in their 20s and 30s, were unwilling to get a booster shot. The study, conducted by researchers from the Barcelona Institute for Global Health (ISGlobal) and the CUNY Graduate School of Public Health and Health Policy (CUNY SPH), and published in Nature Medicine, highlights the need for country-specific communication tactics to combat vaccination reluctance.
In 2020, a group of researchers headed by Lazarus and Ayman El-Mohandes, dean of the CUNY School of Public Health, began conducting surveys in 23 of the most populous nations to collect data for this study. The United States, China, the United Kingdom, Sweden, Russia, and other countries make up the list. This information is from the third survey, which was carried out in June and July of 2022.
A total of 23,00 people took part in the survey, and 79.1 percent of them said they would be vaccinated. As compared to the previous estimate from June of 2021, this result showed an increase of 5.2%. Parental vaccination acceptance increased from 67.6% in 2021 to 69.5% in 2022. Eight nations, nevertheless, saw a rise in uncertainty. Uncomfortably, one-eighth of the vaccinated participants were unsure about receiving booster shots. Younger people were more likely to show this hesitation.
In addition, the poll adds to our understanding of how people with COVID-19 have responded to therapy thus far. While the World Health Organization and other organizations do not endorse ivermectin for the prevention or treatment of COVID-19, its usage is as common as that of other authorized drugs.
Nearly as many respondents (38%) said they were less likely to support vaccination requirements because of the latest information on COVID-19.
Health system decision-makers, practitioners, activists, and researchers may all benefit from the survey data supplied to better address COVID-19 vaccination reluctance. After a worldwide consensus declaration was released on eliminating COVID-19 as a public health issue, a fresh research was conducted on the topic.